India to Spend $1.1 Billion to Make Biopharma Production Hub

India will invest 100 billion rupees ($1.1 billion) in biopharmaceutical research over the next five years as part of a broader push to scale up domestic manufacturing, signaling a renewed focus on higher-value drug development.

The funding will be directed toward the research and production of biologics and biosimilar medicines, with the government targeting to position the country as a global biopharma manufacturing hub, Finance Minister Nirmala Sitharaman said in Parliament on Sunday.